Abnormal apocrine secretory cell mitochondria in a Huntington disease patient

Christos Sidiropoulos1, Peter LeWitt, Ken Hashimoto

  • 1Department of Neurology, Henry Ford Hospital, Wayne State University School of Medicine, Detroit, MI 48322, USA.

Insights

Huntington's disease (HD) involves mitochondrial abnormalities, particularly in apocrine cells, affecting involuntary movements. These cellular changes suggest a systemic mitochondrial disturbance in patients with HD.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Genetics

Background:

  • Huntington's disease (HD) is a progressive neurodegenerative disorder.
  • Characterized by chorea, dystonia, and tics, often with a late onset.
  • Genetic testing reveals CAG repeat expansion in the HTT gene.

Observation:

  • A 42-year-old woman presented with a 20-year history of movement disorders.
  • Diagnosis of HD confirmed by PET scan and genetic testing.
  • Skin biopsy showed unique mitochondrial abnormalities in apocrine secretory cells.

Findings:

  • Mitochondria in apocrine cells were enlarged, rounded, with disrupted cristae and myelin figures.
  • Apocrine cells contained abundant lipid vacuoles and vesicles.
  • Skeletal muscle histology and mitochondrial function tests were normal in this patient.

Implications:

  • Mitochondrial dysfunction may be a systemic feature of Huntington's disease.
  • Similar mitochondrial changes observed in neurons, muscle, fibroblasts, and lymphoblasts of other HD patients.
  • Further research into mitochondrial pathways could reveal novel therapeutic targets for HD.

Related Concept Videos

Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
ATP Synthase: Mechanism01:48

ATP Synthase: Mechanism

In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased ATP...
Translocation of Proteins into the Mitochondria01:19

Translocation of Proteins into the Mitochondria

Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...